These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Kühne T; Imbach P Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290 [TBL] [Abstract][Full Text] [Related]
10. Eltrombopag for the treatment of immune thrombocytopenia. Cheng G Expert Rev Hematol; 2011 Jun; 4(3):261-9. PubMed ID: 21671710 [TBL] [Abstract][Full Text] [Related]
11. Eltrombopag for use in children with immune thrombocytopenia. Kim TO; Despotovic J; Lambert MP Blood Adv; 2018 Feb; 2(4):454-461. PubMed ID: 29487060 [TBL] [Abstract][Full Text] [Related]
15. Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Jenkins JM; Williams D; Deng Y; Uhl J; Kitchen V; Collins D; Erickson-Miller CL Blood; 2007 Jun; 109(11):4739-41. PubMed ID: 17327409 [TBL] [Abstract][Full Text] [Related]
16. Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders. Pathak S; Roth M; Verma A; Steidl U Expert Opin Drug Metab Toxicol; 2013 Dec; 9(12):1667-75. PubMed ID: 24215532 [TBL] [Abstract][Full Text] [Related]
17. Eltrombopag for the treatment of idiopathic thrombocytopenic purpura. Stasi R Expert Rev Hematol; 2008 Dec; 1(2):145-52. PubMed ID: 21082919 [TBL] [Abstract][Full Text] [Related]
18. Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study. Bussel JB; de Miguel PG; Despotovic JM; Grainger JD; Sevilla J; Blanchette VS; Krishnamurti L; Connor P; David M; Boayue KB; Matthews DC; Lambert MP; Marcello LM; Iyengar M; Chan GW; Chagin KD; Theodore D; Bailey CK; Bakshi KK Lancet Haematol; 2015 Aug; 2(8):e315-25. PubMed ID: 26688484 [TBL] [Abstract][Full Text] [Related]
19. [Development of myelofibrosis during eltrombopag treatment in a patient with immune thrombocytopenia]. Horikoshi A; Tsukuda J; Abe R; Fujiwara N; Ito E; Takaku T Rinsho Ketsueki; 2016 May; 57(5):638-41. PubMed ID: 27263792 [TBL] [Abstract][Full Text] [Related]
20. Eltrombopag in chronic hepatitis C. Mihăilă RG; Cipăian RC World J Gastroenterol; 2014 Sep; 20(35):12517-21. PubMed ID: 25253952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]